Sunday, August 04, 2024 11:25:35 PM
Granted, Northwest Bio’s application was submitted right before the Christmas and New Year’s holidays, when many government agency employees are given a couple of weeks off, so it seems that the application wasn’t validated as quickly as it normally would have been, but it doesn’t make sense to me that it took anywhere near 78 days for validation and the start of assessment.
On a related side note:
Why would Linda and Les both think that Northwest Bio’s application has received priority review from the MHRA, and is being assessed under the 150-day accelerated pathway?
Because Linda and Les are in the perfect position to know. They have been overseeing the responses to the MHRA’s questions about the application, they understand how each phase of the assessment works, and approximately where the MHRA is in the review process. And more importantly . . . they know this because the MHRA recently began providing applicants with the ability to track a marketing application through the review process:
RegulatoryConnect
The Medicines and Healthcare Regulatory Agency have launched RegulatoryConnect, a service that provides the capability to track applications and view live authorisation details.
From:
Medicines and Healthcare products Regulatory Agency
Published
25 March 2024
Last updated
15 April 2024 — See all updates
The RegulatoryConnect portal will provide greater transparency and visibility for regulatory assessments to industry. The functionality will let industry users log in using existing MHRA submission credentials and access RegulatoryConnect, where they will be able to:
* Use the Applications page to track the status of an application and see which stage it is at.
* Use the Current Granted View page to view live authorisation details, including status, key data and documents held against existing licences.
These services are available to those making applications to the MHRA on behalf of their organisation as an administrator or user.
Future functionality and features will be added to RegulatoryConnect later in the year, including the ability to submit applications and variations to the MHRA through the service.
https://www.gov.uk/guidance/regulatoryconnect
RegulatoryConnect guidance
Navigating the RegulatoryConnect portal
Published March 2024
https://assets.publishing.service.gov.uk/media/65fc55b8a6c0f70011ef91db/RegulatoryConnect_-_Navigating_the_RegulatoryConnect_portal.pdf
Understanding application statuses
Published March 2024
https://assets.publishing.service.gov.uk/media/65fc55b865ca2f00117da815/RegulatoryConnect_-_Understanding_application_statuses.pdf
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
